Pharmacy-based Testing and Treatment for Gonorrhea and Chlamydia

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Chlamydia Trachomatis InfectionNeisseria Gonorrheae Infection
Interventions
OTHER

Chlamydia trachomatis and Neisseria gonorrhea self-swab(s) and/or urine collection. Clinical assessment and prescribing of treatment for participants with positive test results

Participants will be tested by self-swab sample (pharyngeal, vaginal or rectal) and/or urine sample (urogenital) for Chlamydia trachomatis and Neisseria gonorrhea. Selection of swab(s) or urine-based testing will be determined by the individual's sexual risk factors. Participants who have positive CT and/or NG test results will undergo clinical assessment of the CT and/or NG infection by the pharmacist and a prescription will be issued for treatment as appropriate.

Trial Locations (5)

Unknown

Brookline Pharmacy, Bedford

Moffatt's Pharmacy, Dartmouth

Boyd's Pharmasave, Halifax

SRx Pharmacy, Halifax

B3H 3A6

Queen Elizabeth II Health Sciences Centre, Halifax

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER

collaborator

Dalhousie University

OTHER

NCT06234943 - Pharmacy-based Testing and Treatment for Gonorrhea and Chlamydia | Biotech Hunter | Biotech Hunter